CCND1 and cancer: Moreover, Dyrk1B has been reported to control cyclin D1 levels in HeLa cells treated with differentiation-inducing factor-3 (DIF-3) by affecting DIF-3-induced cyclin D1 phosphorylation and degradation [35], in the lung epithelial cell line Mv1Lu [36] and in different cancer cell lines [37].